Portfolio company
Aptatek Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops portable diagnostic devices for home monitoring of biomarkers to help patients manage chronic conditions such as phenylketonuria.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Enzyre
This company develops a portable diagnostic device for haemophilia patients to monitor blood coagulation status and manage treatment from home.
Phenotap
This company develops enzymes for blood glucose and ketone monitoring device manufacturers to enable continuous metabolic tracking and diabetic ketoacidosis detection.
Apieron
This company develops biosensor devices to monitor exhaled nitric oxide for asthma management in patients and clinical settings.
Flux Biosciences
This company develops a portable biosensor platform using magnetic sensing to provide medical-grade diagnostics from blood, urine or saliva for consumers at home.
SiPhox Health
This company provides at-home blood testing kits and a digital tracking platform for consumers to monitor their health biomarkers.
AminoSense
This company develops a biosensor platform for real-time amino acid measurement at home to help consumers optimize protein nutrition and metabolic health.
Beta Bionics
This company develops an autonomous insulin delivery system for children and adults living with type 1 diabetes to manage their glucose levels.
Proton Intelligence
This company develops a wearable continuous potassium monitoring platform for clinicians to manage patients with chronic kidney disease and heart failure.
